Ottaiano, A., De Stefano, A., Capozzi, M., Nappi, A., De Divitiis, C., Romano, C., . . . Avallone, A. (2018). First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis. Front Pharmacol.
Citação norma ChicagoOttaiano, Alessandro, et al. "First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis." Front Pharmacol 2018.
Deismireacht MLAOttaiano, Alessandro, et al. "First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis." Front Pharmacol 2018.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.